Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A.R. Hounsell is active.

Publication


Featured researches published by A.R. Hounsell.


International Journal of Radiation Oncology Biology Physics | 2011

Cell-Specific Radiosensitization by Gold Nanoparticles at Megavoltage Radiation Energies

Suneil Jain; Jonathan A. Coulter; A.R. Hounsell; Karl T. Butterworth; Stephen J. McMahon; Wendy B. Hyland; Mark F. Muir; Glenn R. Dickson; Kevin Prise; Frederick Currell; Joe M. O’Sullivan; David Hirst

PURPOSE Gold nanoparticles (GNPs) have been shown to cause sensitization with kilovoltage (kV) radiation. Differences in the absorption coefficient between gold and soft tissue, as a function of photon energy, predict that maximum enhancement should occur in the kilovoltage (kV) range, with almost no enhancement at megavoltage (MV) energies. Recent studies have shown that GNPs are not biologically inert, causing oxidative stress and even cell death, suggesting a possible biological mechanism for sensitization. The purpose of this study was to assess GNP radiosensitization at clinically relevant MV X-ray energies. METHODS AND MATERIALS Cellular uptake, intracellular localization, and cytotoxicity of GNPs were assessed in normal L132, prostate cancer DU145, and breast cancer MDA-MB-231 cells. Radiosensitization was measured by clonogenic survival at kV and MV photon energies and MV electron energies. Intracellular DNA double-strand break (DSB) induction and DNA repair were determined and GNP chemosensitization was assessed using the radiomimetic agent bleomycin. RESULTS GNP uptake occurred in all cell lines and was greatest in MDA-MB-231 cells with nanoparticles accumulating in cytoplasmic lysosomes. In MDA-MB-231 cells, radiation sensitizer enhancement ratios (SERs) of 1.41, 1.29, and 1.16 were achieved using 160 kVp, 6 MV, and 15 MV X-ray energies, respectively. No significant effect was observed in L132 or DU145 cells at kV or MV energies (SER 0.97-1.08). GNP exposure did not increase radiation-induced DSB formation or inhibit DNA repair; however, GNP chemosensitization was observed in MDA-MB-231 cells treated with bleomycin (SER 1.38). CONCLUSIONS We have demonstrated radiosensitization in MDA-MB-231 cells at MV X-ray energies. The sensitization was cell-specific with comparable effects at kV and MV energies, no increase in DSB formation, and GNP chemopotentiation with bleomycin, suggesting a possible biological mechanism of radiosensitization.


Scientific Reports | 2011

Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles

Stephen J. McMahon; Wendy B. Hyland; Mark F. Muir; Jonathan A. Coulter; Suneil Jain; Karl T. Butterworth; Giuseppe Schettino; Glenn R. Dickson; A.R. Hounsell; Joe M. O'Sullivan; Kevin Prise; David Hirst; Frederick Currell

Gold nanoparticles (GNPs) are being proposed as contrast agents to enhance X-ray imaging and radiotherapy, seeking to take advantage of the increased X-ray absorption of gold compared to soft tissue. However, there is a great discrepancy between physically predicted increases in X-ray energy deposition and experimentally observed increases in cell killing. In this work, we present the first calculations which take into account the structure of energy deposition in the nanoscale vicinity of GNPs and relate this to biological outcomes, and show for the first time good agreement with experimentally observed cell killing by the combination of X-rays and GNPs. These results are not only relevant to radiotherapy, but also have implications for applications of heavy atom nanoparticles in biological settings or where human exposure is possible because the localised energy deposition high-lighted by these results may cause complex DNA damage, leading to mutation and carcinogenesis.


Radiotherapy and Oncology | 2011

Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy

Stephen J. McMahon; Wendy B. Hyland; Mark F. Muir; Jonathan A. Coulter; Suneil Jain; Karl T. Butterworth; Giuseppe Schettino; Glenn R. Dickson; A.R. Hounsell; Joe M. O’Sullivan; Kevin Prise; David Hirst; Frederick Currell

BACKGROUND AND PURPOSE The addition of gold nanoparticles (GNPs) to tumours leads to an increase in dose due to their high density and energy absorption coefficient, making it a potential radiosensitiser. However, experiments have observed radiosensitisations significantly larger than the increase in dose alone, including at megavoltage energies where golds relative energy absorption is lowest. This work investigates whether GNPs create dose inhomogeneities on a sub-cellular scale which combine with non-linear dose dependence of cell survival to be the source of radiosensitisation at megavoltage energies. MATERIALS AND METHODS Monte Carlo simulations were carried out to calculate dose in the vicinity of a single GNP on the nanoscale. The effect of this nanoscale dose distribution was then modelled for MDA-MB-231 cells exposed to 2 nm GNPs, and compared to experimental results. RESULTS Dramatic dose inhomogeneities occur around GNPs exposed to megavoltage radiation. When analysed using the Local Effect Model, these inhomogeneities lead to significant radiosensitisation, in agreement with experimental results. CONCLUSIONS This work suggests that GNP radiosensitisation is driven by inhomogeneities in dose on the nanoscale, rather than changes in dose over the entire cell, which may contribute to the similar radiosensitisation observed in megavoltage and kilovoltage experiments. The short range of these inhomogeneities and the variation in enhancement in different cells suggests sub-cellular localisation is important in determining GNP radiosensitisation.


International Journal of Nanomedicine | 2012

Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles

Jonathan A. Coulter; Suneil Jain; Karl T. Butterworth; Laura E. Taggart; Glenn R. Dickson; Stephen J. McMahon; Wendy B. Hyland; Mark F. Muir; Coleman Trainor; A.R. Hounsell; Joe M. O'Sullivan; Giuseppe Schettino; Frederick Currell; David Hirst; Kevin Prise

Background This follow-up study aims to determine the physical parameters which govern the differential radiosensitization capacity of two tumor cell lines and one immortalized normal cell line to 1.9 nm gold nanoparticles. In addition to comparing the uptake potential, localization, and cytotoxicity of 1.9 nm gold nanoparticles, the current study also draws on comparisons between nanoparticle size and total nanoparticle uptake based on previously published data. Methods We quantified gold nanoparticle uptake using atomic emission spectroscopy and imaged intracellular localization by transmission electron microscopy. Cell growth delay and clonogenic assays were used to determine cytotoxicity and radiosensitization potential, respectively. Mechanistic data were obtained by Western blot, flow cytometry, and assays for reactive oxygen species. Results Gold nanoparticle uptake was preferentially observed in tumor cells, resulting in an increased expression of cleaved caspase proteins and an accumulation of cells in sub G1 phase. Despite this, gold nanoparticle cytotoxicity remained low, with immortalized normal cells exhibiting an LD50 concentration approximately 14 times higher than tumor cells. The surviving fraction for gold nanoparticle-treated cells at 3 Gy compared with that of untreated control cells indicated a strong dependence on cell type in respect to radiosensitization potential. Conclusion Gold nanoparticles were most avidly endocytosed and localized within cytoplasmic vesicles during the first 6 hours of exposure. The lack of significant cytotoxicity in the absence of radiation, and the generation of gold nanoparticle-induced reactive oxygen species provide a potential mechanism for previously reported radiosensitization at megavoltage energies.


International Journal of Radiation Oncology Biology Physics | 2011

Out-of-field cell survival following exposure to intensity-modulated radiation fields

Karl T. Butterworth; Conor K. McGarry; Colman Trainor; Joe M. O'Sullivan; A.R. Hounsell; Kevin Prise

PURPOSE To determine the in-field and out-of-field cell survival of cells irradiated with either primary field or scattered radiation in the presence and absence of intercellular communication. METHODS AND MATERIALS Cell survival was determined by clonogenic assay in human prostate cancer (DU145) and primary fibroblast (AGO1552) cells following exposure to different field configurations delivered using a 6-MV photon beam produced with a Varian linear accelerator. RESULTS Nonuniform dose distributions were delivered using a multileaf collimator (MLC) in which half of the cell population was shielded. Clonogenic survival in the shielded region was significantly lower than that predicted from the linear quadratic model. In both cell lines, the out-of-field responses appeared to saturate at 40%-50% survival at a scattered dose of 0.70 Gy in DU-145 cells and 0.24 Gy in AGO1522 cells. There was an approximately eightfold difference in the initial slopes of the out-of-field response compared with the α-component of the uniform field response. In contrast, cells in the exposed part of the field showed increased survival. These observations were abrogated by direct physical inhibition of cellular communication and by the addition of the inducible nitric oxide synthase inhibitor aminoguanidine known to inhibit intercellular bystander effects. Additional studies showed the proportion of cells irradiated and dose delivered to the shielded and exposed regions of the field to impact on response. CONCLUSIONS These data demonstrate out-of-field effects as important determinants of cell survival following exposure to modulated irradiation fields with cellular communication between differentially irradiated cell populations playing an important role. Validation of these observations in additional cell models may facilitate the refinement of existing radiobiological models and the observations considered important determinants of cell survival.


Clinical Oncology | 2010

Geometrical analysis of radiotherapy target volume delineation: a systematic review of reported comparison methods.

G.G. Hanna; A.R. Hounsell; J.M. O’Sullivan

Radiotherapy target volume definition is a critical step in the radiotherapy treatment planning process for all tumour sites. New technology may improve the identification of tumour from normal tissue for the purposes of target volume definition. In assessing the proffered benefits of new technologies, rigorous methods of comparison are necessary. A review of published studies was conducted using PubMed (National Library of Medicine) between 1 January 1995 and 1 January 2009 using predefined search terms. The frequency of usage of the various methods of geometrical comparison (simple volume assessment, centre of mass analysis, concordance index and volume edge analysis) was recorded. Sixty-three studies were identified, across a range of primary tumour sites. The most common method of target volume analysis was simple volume measurement; this was described in 84% of the papers analysed. The concordance index type analysis was described in 30%, the centre of mass analysis in 9.5% and the volume edge analysis in 4.8%. In reporting geometrical differences between target volumes no standard exists. However, to optimally describe geometrical changes in target volumes, simple volume change and a measure of positional change should be assessed.


Physics in Medicine and Biology | 1997

Head scatter modelling for irregular field shaping and beam intensity modulation.

A.R. Hounsell; John M Wilkinson

Scattered radiation from within the treatment head can contribute significant dose to all parts of a radiotherapy treatment field. A multileaf collimator may be used to create an arbitrarily shaped field, and may also be used, under dynamic control, to modulate the beam intensity over the field. This method of intensity modulation is effectively a superposition of a large number of fields which have the same beam direction, but different shapes, and some of these shapes may have unusually small dimensions, particularly in the direction of the leaf movement. Two models for predicting the head scatter under these conditions have been investigated. These are a first-order Compton scatter approximation from the flattening filter, and an empirical fit to measured data using an exponential function. The first model only considers scatter from the flattening filter and has been applied to field sizes between 2 cm by 2 cm and 10 cm by 10 cm, where agreements are all within 1%. However it is not satisfactory at larger field sizes where small scatter contributions, from scattering sources other than the flattening filter, are integrated over large areas. The second model uses measured data between 4 cm by 4 cm and 30 cm by 30 cm to optimize the exponential function and is used to calculate the head scatter contribution for all field sizes. In this case good agreement is achieved over the full field size range, and hence this is a more generally applicable model. Results are presented for static irregularly shaped fields and intensity modulated beams created using a Philips multileaf collimator.


Physics in Medicine and Biology | 1999

Electron contamination and build-up doses in conformal radiotherapy fields.

A.R. Hounsell; John M Wilkinson

The dose in the build-up region depends upon the primary photon beam, backscattered radiation from the patient and contamination radiation from outside the patient. In this paper, a model based on measured data is proposed which allows the build-up dose for arbitrarily shaped treatment fields to be determined. The dose in the build-up region is assumed to comprise a primary photon component and a contamination component that is a function of the field size and shape. This contamination component, for modelling purposes, is subdivided into contributions that correspond to elements of 1 cm by 1 cm cross-sectional area at the plane of the isocentre. The magnitude of these components has been obtained by fitting measured data to an exponential function. The exponent was found to vary linearly with depth for energies between 4 MV and 20 MV. The coefficient decreased linearly with depth at 4, 6 and 8 MV, but exhibited a broad build-up region at 20 MV. The primary component, in the build-up region, could be approximated by a 100 - (100 - PSD) e(-mu d) function, where PSD is the primary surface dose. The values obtained during the fitting procedure were used to calculate dose in the build-up region for arbitrarily shaped fields. Good agreement was found in each case.


PLOS ONE | 2013

A Kinetic-Based Model of Radiation-Induced Intercellular Signalling

Stephen J. McMahon; Karl T. Butterworth; Colman Trainor; Conor K. McGarry; Joe M. O’Sullivan; Giuseppe Schettino; A.R. Hounsell; Kevin Prise

It is now widely accepted that intercellular communication can cause significant variations in cellular responses to genotoxic stress. The radiation-induced bystander effect is a prime example of this effect, where cells shielded from radiation exposure see a significant reduction in survival when cultured with irradiated cells. However, there is a lack of robust, quantitative models of this effect which are widely applicable. In this work, we present a novel mathematical model of radiation-induced intercellular signalling which incorporates signal production and response kinetics together with the effects of direct irradiation, and test it against published data sets, including modulated field exposures. This model suggests that these so-called “bystander” effects play a significant role in determining cellular survival, even in directly irradiated populations, meaning that the inclusion of intercellular communication may be essential to produce robust models of radio-biological outcomes in clinically relevant in vivo situations.


British Journal of Radiology | 2015

A review of recent advances in optical fibre sensors for in vivo dosimetry during radiotherapy.

S. O'Keeffe; D. McCarthy; Peter Woulfe; Mark W. D. Grattan; A.R. Hounsell; Dan Sporea; Laura Mihai; I. Vata; Gabriel Leen; Elfed Lewis

This article presents an overview of the recent developments and requirements in radiotherapy dosimetry, with particular emphasis on the development of optical fibre dosemeters for radiotherapy applications, focusing particularly on in vivo applications. Optical fibres offer considerable advantages over conventional techniques for radiotherapy dosimetry, owing to their small size, immunity to electromagnetic interferences, and suitability for remote monitoring and multiplexing. The small dimensions of optical fibre-based dosemeters, together with being lightweight and flexible, mean that they are minimally invasive and thus particularly suited to in vivo dosimetry. This means that the sensor can be placed directly inside a patient, for example, for brachytherapy treatments, the optical fibres could be placed in the tumour itself or into nearby critical tissues requiring monitoring, via the same applicators or needles used for the treatment delivery thereby providing real-time dosimetric information. The article outlines the principal sensor design systems along with some of the main strengths and weaknesses associated with the development of these techniques. The successful demonstration of these sensors in a range of different clinical environments is also presented.

Collaboration


Dive into the A.R. Hounsell's collaboration.

Top Co-Authors

Avatar

Conor K. McGarry

Belfast Health and Social Care Trust

View shared research outputs
Top Co-Authors

Avatar

Kevin Prise

Queen's University Belfast

View shared research outputs
Top Co-Authors

Avatar

Joe M. O'Sullivan

Queen's University Belfast

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Suneil Jain

Queen's University Belfast

View shared research outputs
Top Co-Authors

Avatar

G.G. Hanna

Queen's University Belfast

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Colman Trainor

Queen's University Belfast

View shared research outputs
Researchain Logo
Decentralizing Knowledge